跳至主要内容
临床试验/DRKS00017703
DRKS00017703已完成未知

ADA-auriculoacupuncture as a symptomatic treatment for agitation in people with dementia:a randomized, controlled, rater-blind pilot study - NAP-study

Klinik und Poliklinik für Psychiatrie und Psychotherapie, Klinikum München, LMU München0 个研究点目标入组 40 人开始时间: 2019年12月11日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
65 Years 至 one(—)
性别
All

入选标准

  • age at least 65 years;
  • - dementia, diagnosed by a physician;
  • - clinical agitation in 4 weeks prior to inclusion;
  • - written consent by the patient if capacity for consent is given or written consent by the authorized proxy if an authorized proxy exists.

排除标准

  • - dermal or chondral ear defects that would prevent an acupuncture treatment;
  • - anticoagulation with phenprocoumon, warfarine or multiple anticoagulatory treatment;
  • - elevated risk of bleeding due to coagulatory defects (e.g. hemophilia);
  • - clinically permanent severe agitation, indicating that an acupuncture treatment might be impossible;
  • - known physical resistance in needle-involving situations (e.g. blood collection);
  • - physical resistance of the person during the compliance test (ear disinfection test);
  • - acupuncture treatment during 4 weeks prior to preliminary medical exam;
  • - vagal nerve stimulation treatment during 4 weeks prior to preliminary medical exam.

研究者

发起方
Klinik und Poliklinik für Psychiatrie und Psychotherapie, Klinikum München, LMU München

相似试验